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Abstract
Aim: In China, hand surgeons treat fewer rheumatoid arthritis (RA) patients compared to other countries. We
investigated whether physician and surgeon knowledge, attitudes and practices regarding RA hand deformities
reflect current evidence and may contribute to the low utilization of surgery.
Method: We surveyed hand surgeons and rheumatologists at three tertiary hospitals in Beijing, China. Question-
naires were developed from literature and expert review to assess their knowledge, attitudes and practice patterns
related to rheumatoid hand surgery.
Results: Thirty-five hand surgeons and 59 rheumatologists completed the survey. Roughly one-third felt that
the rheumatologists and hand surgeons agree on how to manage RA hand deformities. One-fifth of rheuma-
tologists and 29% of hand surgeons believed that drug therapy can correct hand deformities, which contra-
dicts current evidence. Likewise, 30% and 14%, respectively, recommended surgery for early-stage hand
sequelae that do not meet current indications for surgery. Over 80% of surgeons and rheumatologists had
no exposure to the other specialty during training and felt their training on the treatment of rheumatoid
hand deformities was inadequate.
Conclusion: Although we found similar interspeciality disagreement in China as is seen in the United States,
there appears to be less interaction through training and consultations. Our results also indicate potential defi-
cits in training and unawareness of evidence and indications for rheumatoid hand surgery. These findings help
to explain why surgery for rheumatoid hand deformities is rare in China; doctors have fewer opportunities to
collaborate across specialties and may not be able to select appropriate candidates for surgery.
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INTRODUCTION
Rheumatoid arthritis (RA) is an autoimmune disease
that causes progressive joint deterioration and affects
the hands in over 70% of patients, leading to functional
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impairment, pain and joint deformities.1 In the United
States, Western Europe and Japan, hand surgery proce-
dures, such as arthroplasty, arthrodesis and tenosyn-
ovectomy, are used to treat advanced RA hand
deformities with good outcomes.2–5 However, in China
where estimates of the prevalence of RA range from
0.28% to 0.45%,6–8 these reconstructive procedures are
rarely performed.5 This anomalous management of RA
hand deformities has not been explained, but may be
related to disagreement among specialists and practice
patterns that are not fully engaged in current evidence-
based medicine.
Metacarpophalangeal (MCP) joint arthroplasty is a
common hand surgery procedure among RA
patients.3,4,9 Long-term prospective outcome investiga-
tions support its ability to reduce hand pain, increase
hand function, correct ulnar drift and achieve favor-
able aesthetic results in patients with advanced joint
disease.4,11,12 Yet prior studies in the United States
demonstrate marked disagreement between rheuma-
tologists and hand surgeons about the indications for
surgery, and variability in practice patterns that can
affect referral for surgery.13 Although these same chal-
lenges may face Chinese doctors, it is likely that
other factors, such as insufficient knowledge and
training, prohibit greater use of RA hand surgery in
China. Among Chinese physicians who treat cancer
patients, for example, misconceptions and lack of
knowledge prevent the proper use of morphine for
cancer pain management, which hampers patients’
quality of life.14 RA joint deformities are a multidisci-
plinary problem best managed by a team of rheuma-
tologists and surgeons.15–17 All doctors involved must
be well versed in the available treatment options and
indications to practice evidence-based medicine and
to appropriately counsel patients.
We undertook a pilot study of hand surgeons and
rheumatologists at three tertiary academic health cen-
ters in Beijing to explore how each specialty approaches
RA hand deformities. Specifically we sought to under-
stand the cause for the low rate of RA hand surgery in
China by investigating the following: rheumatologist
and hand surgeon training and practices; knowledge of
rheumatoid hand deformities; perceptions of the other
specialty; and response to two clinical scenarios to
gauge the knowledge of surgical indications. Using
these data, we compared Chinese rheumatologists and
hand surgeons to assess whether interspeciality dis-
agreement is present and whether self-reported knowl-
edge and practice patterns reflect current evidence. We
hypothesize that the lack of interdisciplinary
collaboration and understanding of evidence-based sur-
gical indications and outcomes contribute to the low
rate of RA hand surgery in China.
METHODS
Our Institutional Review Board approved this method-
ology.
Sample
We obtained convenience samples of rheumatologists
and hand surgeons from three large teaching hospitals in
Beijing during the summer of 2015. All three sites are
prominent institutions in Beijing and nationally with
expertise in internal medicine, scientific research and
hand surgery. Rheumatologists and hand surgeons were
eligible if they were actively practicing in China and had
completed medical school (i.e., Bachelors, Masters or
Doctoral degrees in medicine) and residency training
either in internal medicine or in general, orthopedic or
plastic surgery. Completion of fellowship training was
not a requirement. In addition to staff doctors at these
three hospitals, we also invited visiting professors and
attendees from one morning session of a national
rheumatology conference at one of the sites to participate.
Questionnaires
We developed questionnaires in English based on
review of the relevant literature as well as input from
clinical and methodological collaborators from the
United States and China. Many items were adapted
from previous surveys.5–8,10,11,13,16,18–25 Our survey
instruments captured demographic information, atti-
tudes toward hand surgery, perceptions of the other
specialty, and recommendations regarding surgical
intervention in two clinical scenarios. Both clinical
cases (Appendix 1) focused on MCP joint arthroplasty
because it is recognized as a mainstay of reconstruction
for rheumatoid joint deformities and there is ample evi-
dence for its indications and outcomes. Clinical indica-
tions include radiographic findings of MCP joint
destruction or dislocation, palmar subluxation, ulnar
deviation and interphalangeal joint stiffness.4,9,15,19
Case 1 did not meet these criteria, whereas Case 2 was a
candidate for MCP joint arthroplasty.
Expert review by clinical and methodological collabo-
rators from the United States and China was performed
to evaluate the content, wording and structure of the
surveys.26,27 Two different researchers then translated
the surveys into Chinese and back-translated them to
English. A third compared the back-translation to the
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original English.22 This stepwise method of translation
was used to ensure the accuracy of the survey content.
We revised the Chinese surveys to address any differ-
ences between the original and back-translated versions.
Then clinical collaborators from the Beijing Hospitals
reviewed both questionnaires for content and language.
The final instruments had 26 items for rheumatologists
and 31 for hand surgeons, and took about 10 min to
complete.
Data collection
Rheumatologists and surgeons were recruited from
three hospitals. We approached clinicians before or
after their clinics at two sites, and at the third, rheuma-
tologists were surveyed at a departmental meeting. In
addition, we distributed surveys to all doctors attending
a morning session of the national conference. These
surveys were collected at the end of the presentations.
Surveys were exempt from written informed consent
because participation was restricted to voluntarily com-
pleting an anonymous survey. Each participant was
offered a pen for participating.
Data analysis
Data were organized by medical specialty and descrip-
tive statistics were calculated for questionnaire
responses and demographic data. We compared
responses between specialty groups using Wilcoxon–
Mann–Whitney tests for continuous variables and
Chi-square tests or Fisher exact tests for categorical vari-
ables.
RESULTS
Fifty-nine rheumatologists representing 38 hospitals
from 19 provinces completed the questionnaires.
Thirty-four hand surgeons from Beijing, as well as one
from Taiwan participated. All physicians and surgeons
(100%) approached in the clinic agreed to participate
in the study. From the rheumatology conference, 48
rheumatologists were invited to participate. Thirty-six
(75%) returned completed surveys, of which 25 met
our eligibility criteria (i.e., had completed their resi-
dency training). In our sample, hand surgeons were
older, had been in practice longer, and were more likely
to be male than rheumatologists; 5% of rheumatolo-
gists and 17% of hand surgeons had trained with mem-
bers of the other specialty. Only five doctors had
received training outside of mainland China, including
in England and Taiwan. Detailed respondent character-
istics are shown in Table 1.
Attitudes toward management of rheumatoid
hand deformities
Most rheumatologists (81%) and hand surgeons (80%)






Mean age (range) 37.5 (28–60) 42.5 (26–60) 0.01
Female 66% 14% < 0.0001
Male 34% 86%
Doctoral (MD) degree 36% 49% 0.12
Specialty fellowship 25% 83% < 0.0001
Medical training abroad 5% 6% 0.88
Years in practice
< 5 years 29% 14% 0.005
5–9 years 44% 26%
10–19 years 17% 20%
> 20 years 10% 37%
Trained with the other specialty 5% 17% < 0.0001
Practice devoted to RA patients
0% 0% 6% < 0.0001





Table 1 Respondent characteristics
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RA patients; prior research indicates the prevalence is
around 70%.1 Nearly all respondents agreed that sur-
gery can correct RA hand deformities (Table 2), except
for 8% of rheumatologists (compared to 0% of hand
surgeons, P = 0.007). Hand surgeons were significantly
more likely to endorse the availability of good or excel-
lent evidence supporting MCP joint arthroplasty (49%
vs. 14%, P < 0.0001) and to be satisfied with their abil-
ity to treat RA hand deformities (62% vs. 41%,
P = 0.04). Despite this satisfaction only a minority of
rheumatologists (10%) and hand surgeons (17%) felt
that they had received adequate training in this area.
Attitudes toward the other specialty
Roughly one-third of participants felt that rheumatolo-
gists and hand surgeons agree on how to manage
rheumatoid hand sequelae and less than one-half felt
that the other specialty refers/operates at the appropri-
ate time (Table 3). Hand surgeons were less likely to
report positive views of rheumatologists’ management
than rheumatologists of surgeons’ (40% vs. 53%,
P = 0.07).
Response to clinical cases
Specialists responded differently to the clinical cases
(Appendix 1), which included early (Stage 1) hand
involvement with swan-neck and Boutonniere deformi-
ties (Case 1) and advanced joint disease (Stage 3) with
ulnar deviation and moderate deterioration of articular
cartilage (Case 2). Thirty percent of rheumatologists rec-
ommended MCP arthroplasty in Case 1 compared to
14% of hand surgeons (P = 0.08). There was no differ-
ence for Case 2 (95% vs. 91%, P = 0.50).
DISCUSSION
To assess knowledge and attitudes regarding hand sur-
gery for RA in China, we performed a pilot survey of 59
rheumatologists and 35 hand surgeons at three large
tertiary hospitals in Beijing. Our results show that few
doctors trained with members of the other specialty, yet
more than half report regular consultations to each
other about RA patients. Nearly all respondents agreed
that surgery can correct RA hand deformities. However,
a subset also indicated that drug therapy can do the
same (which it cannot). Surgeons and rheumatologists
disagreed about the availability of good or excellent evi-
dence supporting the use of MCP arthroplasty for RA,
and differed in their recommendations for surgical
treatment for early-stage RA hand deformities. Most
respondents indicated that their training on this topic
was insufficient. Although the interspeciality
Table 2 Attitudes toward management of rheumatoid hand deformities
Rheumatologists (n = 59) Hand surgeons (n = 35) P-value
Satisfied with ability to manage RA hand deformities 41% 62% 0.04
Feel that training received in management of RA hand
deformities was adequate
10% 17% 0.35
Agree that drugs can correct hand deformities 20% 29% 0.21
Agree that surgery can correct RA hand deformities 92% 100% 0.007
Feel there is good or excellent evidence supporting
metacarpophalangeal arthroplasty for RA hand deformities
14% 49% < 0.0001






Feel that rheumatologists and hand surgeons agree on the management
of rheumatoid arthritis patients’ hand disabilities.
31% 37% 0.93
Feel that members of other specialty appropriately manage RA
hand deformities
53% 40% 0.07
Feel that hand surgeons operate on RA patients at the appropriate
time/rheumatologists refer RA patients at the appropriate time
40% 46% 0.13
Feel that hand surgeons are too aggressive in treating RA
patients/rheumatologists are too passive in treating RA patients
40% 57% 0.12
Regularly consult with a hand surgeon/rheumatologist about
my RA patients’ treatments
58% 57% 0.89
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discrepancies are similar to controversies found in the
United States, our results also suggest that doctors in
China are not completely aware of indications for hand
surgery or its benefits compared to drug therapy for
advanced RA joint sequelae.
Despite reporting similar attitudes toward each other
as have been found in American rheumatologists and
hand surgeons, doctors in our study reported less inter-
disciplinary training and active collaboration about RA
patients compared to those in the United States.16
Alderman et al.13 found that 33% of hand surgeons
and 21% of rheumatologists in the United States were
exposed to the other specialty during training, and 78%
and 81%, respectively, have an active referral exchange
with the other specialty. Only 17% of surgeons and 5%
of rheumatologists in this study reported training with
each other and fewer (57%, 58%) reported regularly
consulting with the other specialty. This may contribute
to the lower rates of rheumatoid hand surgery observed
in China compared to the United States, as coordina-
tion is key for operative management of RA hand defor-
mities. Careful selection of patients and planning are
necessary for hand surgery, a local intervention, to be
applied correctly within the context of a systemic dis-
ease.
Our data suggest an insufficient knowledge of current
evidence regarding rheumatoid hand surgery among
rheumatologists and hand surgeons in China, which is
concerning because it could preclude judicious applica-
tions of procedures such as MCP joint arthroplasty.
First, 20% of rheumatologists and 29% of hand sur-
geons believed that drug therapy can correct RA hand
deformities. Medication management is indispensable
for controlling RA, but it cannot alter hand deformities
or joint destruction once these sequelae have occurred.
Second, 30% of rheumatologists and 14% of hand sur-
geons recommended MCP arthroplasty in the first clini-
cal scenario (Stage 1 RA), which does not meet
established clinical indications for this intervention.
Lastly, only 10% of rheumatologists and 17% of hand
surgeons felt that they received adequate training in the
management of RA hand deformities. This implies that
doctors, particularly non-surgeons, are not fully pre-
pared to treat RA hand deformities or are familiar with
literature about their management. This may impair
their ability to make appropriate referrals and could
translate into misconceptions among patients who rely
on rheumatologists to guide RA treatment decisions.
Hand surgeons must also be aware of when and if to
intervene, as patient selection is very important to
achieving good outcomes.15
Several limitations apply to this study. Our samples
were modest and collected from one city. Beijing and
other large cities in China, such as Shanghai, have
advanced medical care that may not be available in
smaller cities where barriers related to low knowledge
of indications and evidence are likely to be even more
prevalent. To enhance geographic diversity, we included
doctors visiting from other provinces. Next, we asked
participants to self-report attitudes and knowledge,
which may not directly reflect practice patterns. Lastly,
the appropriateness of reconstruction for RA hand
deformities is subject to other factors that were not
addressed in this study, such as the patients’ needs and
preferences, comorbidities, acclimation to hand symp-
toms and disease control.15 However, the scope of this
study was to assess clinicians’ knowledge of surgical
indications, which we were able to capture by asking
whether or not they would recommend intervention in
specific clinical scenarios.
The findings from this survey of 94 rheumatologists
and hand surgeons highlight the issue of low rates of
rheumatoid hand surgery in China and help to illumi-
nate clinician-related factors that contribute. Namely, it
uncovered interspeciality disagreements and inadequa-
cies in training that could hurt collaborative relation-
ships and limit clinical expertise, as well as
recommendations and beliefs about the treatment of
RA hand deformities that do not adhere to current evi-
dence. These issues create barriers to RA patient care
and rheumatoid hand surgery. Through highlighting
them, we hope to encourage and broaden access to evi-
dence-based management of rheumatoid hand condi-
tions in China.
ACKNOWLEDGEMENTS
Research reported in this publication was supported by
the National Institute of Arthritis and Musculoskeletal
and Skin Diseases of the National Institutes of Health
under Award Number 2 K24-AR053120-06. The con-
tent is solely the responsibility of the authors and does
not necessarily represent the official views of the
National Institutes of Health.
REFERENCES
1 de la Mata LJ, Palacios Carvajal J (1998) Rheumatoid
arthritis: are outcomes better with medical or surgical
management? Orthopedics 21, 1085–6.
2 Anderson RJ (2011) Controversy in the surgical treatment
of the rheumatoid hand. Hand Clin 27 (1), 21–5.
1974 International Journal of Rheumatic Diseases 2018; 21: 1970–1976
L.E. Franzblau et al.
3 Chim HW, Reese SK, Toomey SN, Moran SL (2014) Update
on the surgical treatment for rheumatoid arthritis of the
wrist and hand. J Hand Ther 27 (2), 134–41; quiz 42.
4 Goldfarb CA, Dovan TT (2006) Rheumatoid arthritis: sili-
cone metacarpophalangeal joint arthroplasty indications,
technique, and outcomes. Hand Clin 22, 177–82.
5 Kotsis SV, Chung KC (2005) A qualitative assessment of
rheumatoid hand surgery in various regions of the world.
J Hand Surg 30, 649–57.
6 Xu C, Wang X, Mu R et al. (2014) Societal costs of
rheumatoid arthritis in China: a hospital-based cross-sec-
tional study. Arthritis Care Res 66, 523–31.
7 Zeng QY, Chen R, Darmawan J et al. (2008) Rheumatic
diseases in China. Arthritis Res Ther 10 (1), R17.
8 Li R, Sun J, Ren LM et al. (2012) Epidemiology of eight
common rheumatic diseases in China: a large-scale cross-
sectional survey in Beijing. Rheumatology 51, 721–9.
9 Moran SL, Bishop AT (2007) Clinical update: surgical
management of rheumatoid hand. Lancet 370, 372–4.
10 Zhao S, Chen Y, Chen H (2015) Sociodemographic factors
associated with functional disability in outpatients with
rheumatoid arthritis in Southwest China. Clin Rheumatol
34, 845–51.
11 Chung KC, Nellans KW, Burns PB et al. (2015) Patient
expectations and long-term outcomes in rheumatoid
arthritis patients: results from the SARA (Silicone Arthro-
plasty in Rheumatoid Arthritis) study. Clin Rheumatol 34,
641–51.
12 Wolfe F, Zwillich SH (1998) The long-term outcomes of
rheumatoid arthritis: a 23-year prospective, longitudinal
study of total joint replacement and its predictors in 1,600
patients with rheumatoid arthritis. Arthritis Rheum 41,
1072–82.
13 Alderman AK, Ubel PA, Kim HM, Fox DA, Chung KC
(2003) Surgical management of the rheumatoid hand:
consensus and controversy among rheumatologists and
hand surgeons. J Rheumatol 30, 1464–72.
14 Yanjun S, Changli W, Ling W et al. (2010) A survey on
physician knowledge and attitudes towards clinical use of
morphine for cancer pain treatment in China. Support Care
Cancer 18, 1455–60.
15 Chung KC, Pushman AG (2011) Current concepts in the
management of the rheumatoid hand. J Hand Surg 36,
736–47; quiz 47.
16 Alderman AK, Chung KC, Kim HM, Fox DA, Ubel PA
(2003) Effectiveness of rheumatoid hand surgery: con-
trasting perceptions of hand surgeons and rheumatolo-
gists. J Hand Surg 28 (1), 3–11; discussion 2–3.
17 Siddle HJ, Backhouse MR, Monkhouse R, Harris NJ, Helli-
well PS (2011) Joint orthopaedic and rheumatology clin-
ics: evidence to support the guidelines. Musculoskelet Care
9, 180–3.
18 Cheung KW, Chung SL, Chung KY, Chiu KH (2013)
Patient perception and knowledge on total joint replace-
ment surgery. Hong Kong Med J 19 (1), 33–7.
19 Chung KC, Burns PB, Wilgis EF et al. (2009) A multicenter
clinical trial in rheumatoid arthritis comparing silicone
metacarpophalangeal joint arthroplasty with medical
treatment. J Hand Surg 34, 815–23.
20 Zhang P, Li J, Han Y, Yu XW, Qin L (2010) Traditional
Chinese medicine in the treatment of rheumatoid arthritis:
a general review. Rheumatol Int 30, 713–8.
21 Lv QW, Zhang W, Shi Q et al. (2015) Comparison of
Tripterygium wilfordii Hook F with methotrexate in the
treatment of active rheumatoid arthritis (TRIFRA): a ran-
domised, controlled clinical trial. Ann Rheum Dis 74,
1078–86.
22 Wang XS, Tang JY, Zhao M, Guo H, Mendoza T, Cleeland
CS (2003) Pediatric cancer pain management practices
and attitudes in China. J Pain Sympt Manag 26, 748–59.
23 Feng Z, Zhan HJ, Feng X, Liu C, Sun M, Mor V (2011) An
industry in the making: the emergence of institutional
elder care in urban china. J Am Geriat Soc 59, 738–44.
24 Chung KC, Kotsis SV, Kim HM, Burke FD, Wilgis EF
(2006) Reasons why rheumatoid arthritis patients seek
surgical treatment for hand deformities. J Hand Surg 31,
289–94.
25 Yip WC, Hsiao WC, Chen W, Hu S, Ma J, Maynard A
(2012) Early appraisal of China’s huge and complex
health-care reforms. Lancet 379, 833–42.
26 Survey Research Center (2016). Guidelines for Best Prac-
tice in Cross-Cultural Surveys. Ann Arbor, MI: Survey
Research Center, Institute for Social Research, University
of Michigan. Retrieved October 1, 2015, from
http://www.ccsg.isr.umich.edu/.
27 Groves RM (2009) Survey Methodology, 2nd edn, 461 pp.
Wiley, Hoboken, NJ.
Appendix 1: Clinical Cases
Case 1: A 60-year-old woman with rheumatoid arthritis
who is otherwise healthy presents to you for treatment.
She has synovitis at the metacarpophalangeal joints,
minimal ulnar deviation, and little extension lag of the
fingers. She does not complain of pain and has little
trouble completing daily tasks except when her joints
are swollen in the morning (see picture below).
In your clinical opinion, would this patient benefit
from metacarpophalangeal arthroplasty?
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a. Yes
b. No
If she would benefit from metacarpophalangeal
arthroplasty, how soon should she have it? Leave blank
if you answered ‘No’ to the previous question.
a. As soon as possible
b. During the next 6 months
c. During the next year
d. More than 1 year from now
Case 2: A 60-year-old woman with rheumatoid arthri-
tis who is otherwise healthy presents to you for treat-
ment. Her radiographs show moderate erosion of the
articular cartilage. She does not complain of pain but
has difficulty completing some activities of daily living
(such as doing up buttons or holding a glass) because
of her ulnar deviation and the inability to flex her fin-
gers wide and grasp onto objects. (See picture below).




If she would benefit from metacarpophalangeal
arthroplasty, how soon should she have it? Leave blank
if you answered ‘No’ to the previous question.
a. As soon as possible
b. During the next 6 months
c. During the next year
d. More than 1 year from now
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